Abstract
Previous research finds higher stock prices for firms with extended EPS meet-or-beat streaks benchmarked to analysts’ forecasts. Due to the different persistence and reliability properties of firms’ revenue and expenses, in this study, I test whether stock valuations are different when EPS streaks are extended by firms meeting their revenue versus expense targets. I find that EPS meet-or-beat streaks that are primarily extended by firms meeting-or-beating analysts’ revenue forecasts are positively valued by the market but EPS streaks extended by meeting implied-expense targets are not associated with valuations. I also find revenue and EPS meet-or-beat streaks are independently and positively associated with firm valuations and extended expense meet-or-beat streaks are negatively associated with firm equity valuations. These relationships are stronger for growth firms and firms that report research and development expenses. In short, my results suggest investors only value firms’ ability to consistently meet their revenue forecasts.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.